Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,9228
USD
|
+1,13%
|
|
-9,53%
|
-33,13%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
5.426
|
4.855
|
2.872
|
700,4
|
573,7
|
177,9
|
177,9
|
-
|
Bedrijfswaarde
1 |
4.194
|
3.749
|
1.721
|
400,9
|
393,4
|
-62,74
|
71,98
|
114,1
|
K/w-verhouding
|
-9,29
x
|
-6,13
x
|
-4,35
x
|
-0,84
x
|
-2,04
x
|
-0,55
x
|
-0,58
x
|
-1,12
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
99,4
x
|
109
x
|
11,5
x
|
191
x
|
160
x
|
4,75
x
|
1,42
x
|
0,69
x
|
Bedrijfswaarde/omzet
|
76,8
x
|
83,9
x
|
6,86
x
|
109
x
|
109
x
|
-1,68
x
|
0,57
x
|
0,44
x
|
Bedrijfswaarde/EBITDA
|
-7,56
x
|
-4,7
x
|
-2,85
x
|
-0,7
x
|
-1,04
x
|
0,24
x
|
-0,32
x
|
-0,83
x
|
Bedrijfswaarde/FCF
|
-8,94
x
|
-5,9
x
|
-3,45
x
|
-0,62
x
|
-
|
0,19
x
|
-0,22
x
|
-0,49
x
|
FCF Yield
|
-11,2%
|
-16,9%
|
-29%
|
-162%
|
-
|
521%
|
-449%
|
-206%
|
Price to Book
|
2,88
x
|
3,78
x
|
2,12
x
|
1,9
x
|
2,92
x
|
0,45
x
|
1,26
x
|
1,47
x
|
Aantal aandelen (in duizenden)
|
54.694
|
55.331
|
66.373
|
70.107
|
82.910
|
192.742
|
192.742
|
-
|
Referentieprijs
2 |
99,20
|
87,75
|
43,27
|
9,990
|
6,920
|
0,9228
|
0,9228
|
0,9228
|
Datum van publicatie
|
21/02/19
|
18/02/20
|
23/02/21
|
4/03/22
|
29/03/23
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
54,58
|
44,67
|
250,7
|
3,662
|
3,597
|
37,41
|
125,4
|
257,9
|
EBITDA
1 |
-554,9
|
-797,4
|
-603,7
|
-571,3
|
-379,2
|
-266,4
|
-226,3
|
-138,2
|
Bedrijfsresultaat (EBIT)
1 |
-572
|
-814,8
|
-623
|
-590,9
|
-384,2
|
-283
|
-259,5
|
-177,3
|
Operationele Marge
|
-1.048,06%
|
-1.823,94%
|
-248,49%
|
-16.136,29%
|
-10.679,79%
|
-756,35%
|
-206,96%
|
-68,72%
|
Resultaat voor belastingen (EBT)
1 |
-555,4
|
-790,2
|
-618
|
-562,4
|
-266,5
|
-198,8
|
-244,6
|
-154,5
|
Nettowinst (verlies)
1 |
-555,6
|
-789,6
|
-618,7
|
-819,4
|
-266,6
|
-199,1
|
-236,3
|
-155,2
|
Nettomarge
|
-1.018,02%
|
-1.767,49%
|
-246,75%
|
-22.375,15%
|
-7.411,12%
|
-532,17%
|
-188,44%
|
-60,16%
|
WPA
2 |
-10,68
|
-14,31
|
-9,950
|
-11,89
|
-3,390
|
-1,664
|
-1,597
|
-0,8228
|
Free Cash Flow
1 |
-469,2
|
-635,4
|
-499,3
|
-650,1
|
-
|
-327
|
-323
|
-235
|
FCF-marge
|
-859,6%
|
-1.422,33%
|
-199,15%
|
-17.753,74%
|
-
|
-874,06%
|
-257,62%
|
-91,11%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
21/02/19
|
18/02/20
|
23/02/21
|
4/03/22
|
29/03/23
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
7,472
|
22,68
|
1,606
|
1,945
|
1,519
|
0,071
|
0,062
|
2,381
|
6,89
|
12,39
|
13,88
|
19,23
|
21,78
|
31,92
|
51,67
|
EBITDA
1 |
-234,8
|
-190,8
|
-133,4
|
-119,3
|
-99,42
|
-85,09
|
-75,31
|
-83,41
|
-84,33
|
-83,66
|
-102,3
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-240,8
|
-196,8
|
-135,7
|
-120,3
|
-100,8
|
-86,48
|
-76,56
|
-84,49
|
-85,3
|
-84,73
|
-86,74
|
-75,75
|
-71,82
|
-65,3
|
-53,19
|
Operationele Marge
|
-3.223,21%
|
-867,75%
|
-8.447,51%
|
-6.187,46%
|
-6.633,38%
|
-121.802,82%
|
-123.491,94%
|
-3.548,64%
|
-1.237,98%
|
-683,74%
|
-624,78%
|
-393,92%
|
-329,75%
|
-204,55%
|
-102,96%
|
Resultaat voor belastingen (EBT)
1 |
-241,5
|
-216,9
|
-132,2
|
-122,2
|
-100,1
|
-76,51
|
32,34
|
21,24
|
-72,99
|
-71,73
|
-78,41
|
-70,02
|
-66,45
|
-59,75
|
-46,35
|
Nettowinst (verlies)
1 |
-241,7
|
-216,8
|
-155,1
|
-122,2
|
-100,1
|
-76,52
|
32,23
|
21,24
|
-72,91
|
-71,73
|
-82,49
|
-67,86
|
-65,86
|
-59,02
|
-44,75
|
Nettomarge
|
-3.234,77%
|
-956,11%
|
-9.654,55%
|
-6.280,31%
|
-6.592,36%
|
-107.774,65%
|
51.987,1%
|
892,06%
|
-1.058,17%
|
-578,85%
|
-594,19%
|
-352,91%
|
-302,37%
|
-184,89%
|
-86,62%
|
WPA
2 |
-3,580
|
-3,160
|
-2,140
|
-1,660
|
-1,360
|
-0,9400
|
0,3800
|
0,2100
|
-0,6700
|
-0,6600
|
-0,6291
|
-0,4289
|
-0,4211
|
-0,3678
|
-0,2988
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/08/21
|
5/11/21
|
4/03/22
|
9/05/22
|
4/08/22
|
7/11/22
|
29/03/23
|
9/05/23
|
8/08/23
|
7/11/23
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.232
|
1.106
|
1.151
|
300
|
180
|
241
|
106
|
63,8
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-469
|
-635
|
-499
|
-650
|
-
|
-327
|
-323
|
-235
|
ROE (netto-inkomsten/eigen vermogen)
|
-31,7%
|
-49,8%
|
-46,9%
|
-94,8%
|
-93,4%
|
-105%
|
-122%
|
-113%
|
ROA (netto-inkomsten/totale activa)
|
-26,8%
|
-39,8%
|
-35,3%
|
-69%
|
-
|
-40,5%
|
-80,2%
|
-88,1%
|
Totale activa
1 |
2.072
|
1.985
|
1.754
|
1.188
|
-
|
492,2
|
294,7
|
176,1
|
Nettoactief per aandeel
2 |
34,40
|
23,20
|
20,40
|
5,260
|
2,370
|
2,040
|
0,7300
|
0,6300
|
Cashflow per aandeel
2 |
-7,950
|
-10,20
|
-7,560
|
-9,220
|
-4,490
|
-1,720
|
-1,130
|
-0,7400
|
Capex
1 |
55,7
|
71
|
29
|
14,5
|
8,21
|
6,99
|
6,56
|
6,52
|
Capex/omzet
|
102,12%
|
158,99%
|
11,56%
|
396,04%
|
228,19%
|
18,68%
|
5,23%
|
2,53%
|
Datum van publicatie
|
21/02/19
|
18/02/20
|
23/02/21
|
4/03/22
|
29/03/23
|
-
|
-
|
-
|
Laatste slotkoers
0,9228
USD Gemiddelde koersdoel
4,062
USD Spread / Gemiddelde doel +340,15% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -33,13% | 178 mln. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|